Get the Stockscreener App
0.00
100.00%
-17.16
Ikena Oncology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
See More
Previous Close:
$17.16
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$59.90M
Revenue:
$9.16M
Net Income/Loss:
$-68.17M
P/E Ratio:
0.00
EPS:
-1.63
Net Cash Flow:
$-80.16M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.28
Ikena Oncology Inc Stock (IKNA) Company Profile
Name
Ikena Oncology Inc
Sector
Industry
Phone
857-343-8292
Address
50 NORTHERN AVE., BOSTON
Compare IKNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
0.00 | 59.90M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-24 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-22-23 | Initiated | Wedbush | Outperform |
| May-04-23 | Resumed | H.C. Wainwright | Buy |
| Dec-23-21 | Initiated | H.C. Wainwright | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Jefferies | Buy |
| Apr-20-21 | Initiated | William Blair | Outperform |
View All
Ikena Oncology Inc Stock (IKNA) Latest News
Relative strength of Ikena Oncology Inc. in sector analysisTrade Entry Report & Weekly Setup with ROI Potential - newser.com
Published on: 2025-09-15 11:10:32 - newser.com
Growth Value: Can Ikena Oncology Inc lead its sector in growthJuly 2025 Fed Impact & Consistent Growth Equity Picks - خودرو بانک
Advanced analytics toolkit walkthrough for Ikena Oncology Inc.Portfolio Return Summary & Risk Controlled Stock Pick Alerts - newser.com
Is Ikena Oncology Inc. still worth holding after the dipWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Ikena Oncology Inc. stock recover after recent dropAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Live market analysis of Ikena Oncology Inc.Earnings Performance Report & Risk Controlled Swing Alerts - newser.com
What candlestick patterns are forming on Ikena Oncology Inc.2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com
Will Ikena Oncology Inc. price bounce be sustainableProduct Launch & Safe Entry Trade Signal Reports - newser.com
Should you wait for a breakout in Ikena Oncology Inc.Dividend Hike & Weekly Breakout Watchlists - newser.com
Using Ichimoku Cloud for Ikena Oncology Inc. technicalsSwing Trade & Real-Time Volume Trigger Notifications - newser.com
Is Ikena Oncology Inc. showing signs of accumulationMarket Rally & Fast Exit Strategy with Risk Control - newser.com
How institutional ownership impacts Ikena Oncology Inc. stockSell Signal & Free Safe Entry Trade Signal Reports - newser.com
Key metrics from Ikena Oncology Inc.’s quarterly dataJuly 2025 Outlook & Community Supported Trade Ideas - Newser
Measuring Ikena Oncology Inc.’s beta against major indices2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
Is Ikena Oncology Inc. reversing from oversold territory2025 Major Catalysts & Growth Oriented Trading Recommendations - Newser
Has Ikena Oncology Inc. found a price floorWeekly Risk Report & Safe Entry Momentum Tips - Newser
How to track smart money flows in Ikena Oncology Inc.July 2025 News Drivers & Intraday High Probability Setup Alerts - Newser
Applying Elliott Wave Theory to Ikena Oncology Inc.2025 Macro Impact & Free Safe Capital Growth Stock Tips - Newser
Multi factor analysis applied to Ikena Oncology Inc.July 2025 Price Swings & Verified Entry Point Signals - Newser
Published on: 2025-09-12 13:59:20 - Newser
Leading vs lagging indicators on Ikena Oncology Inc. performanceDip Buying & AI Enhanced Trading Alerts - Newser
Quantitative breakdown of Ikena Oncology Inc. recent moveEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
What moving averages say about Ikena Oncology Inc.2025 Trading Volume Trends & Stock Timing and Entry Methods - Newser
How hedge fund analytics apply to Ikena Oncology Inc. stock2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Earnings visualization tools for Ikena Oncology Inc.IPO Watch & Free Growth Oriented Trading Recommendations - Newser
Chart overlay techniques for tracking Ikena Oncology Inc.July 2025 Price Swings & Reliable Breakout Forecasts - Newser
Published on: 2025-09-11 23:02:30 - Newser
Regression analysis insights on Ikena Oncology Inc. performanceEarnings Beat & Verified High Yield Trade Plans - Newser
Institutional scanner results for Ikena Oncology Inc.Quarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
Does Ikena Oncology Inc. fit your quant trading modelBreakout Watch & Weekly Chart Analysis and Guides - Newser
Published on: 2025-09-11 04:45:06 - Newser
What recovery options are there for Ikena Oncology Inc.July 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
What MACD and RSI say about Ikena Oncology Inc.Gap Up & Weekly Chart Analysis and Trade Guides - Newser
Ikena Oncology Inc Stock (IKNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):